May 29, 2025

Our 2024 Annual Report Is Here

In 2024, the Foundation made exciting progress toward our mission. The FDA approved a new, once-a-day modulator for people with cystic fibrosis, Alyftrek. In addition, we supported clinical trials for transformative treatments for everyone with CF, worked to address ongoing health needs and support tailored care, advocated at the state level, expanded online offerings, and so much more. Explore our annual report to see key details of the progress we are making together.

See our annual report »

REACH Study: Be Part of the Future of Cystic Fibrosis Treatments 

Are you living with cystic fibrosis but not on CFTR modulators? The REACH study is actively enrolling participants like you to share health info and blood samples. By participating, you can help shape the future of CF treatment for those who don't respond to current therapies. 

Join the study »

Expand Your Impact Beyond CF Awareness Month 

As CF Awareness Month comes to a close, we are grateful to everyone in the CF community who celebrated and reminded us of what we can achieve together. However, our work isn’t finished until every person with CF can live a long, fulfilling life. Whether you’re interested in volunteering with your local chapter, participating in advocacy efforts, connecting with peers, or something else, there are meaningful ways to get involved all year long. 

Get involved »

From the CF Community Blog: I Thought I Had CF Under Control. Then I Was Diagnosed With CF-Related Diabetes

When Lauren Harvey moved away for college, she was determined to prove that she could manage her CF by herself. But she was thrown for a loop when she was unexpectedly diagnosed with CF-related diabetes.  

Read Lauren's story »